Earth Science Tech (ETST) Change in Receivables (2011 - 2026)
Earth Science Tech's (ETST) quarterly Change in Receivables came in at $49936.0 in Q1 2026, up 242.04% YoY from $14599.6 in Q1 2025, and down 36.73% on a QoQ basis from $78929.0 in Q4 2025.
Earth Science Tech (ETST) Change in Receivables (2011 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 7 years of Change in Receivables data on file, last reported at $49936.0 in Q1 2026.
- Quarterly Change in Receivables rose 242.04% year-over-year to $49936.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $226990.0 (up 313.42% YoY) and the FY2026 annual result came in at $226990.0, up 313.42% from the prior year.
- Change in Receivables slipped to $49936.0 in Q1 2026, from $78929.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $212580.0 in Q2 2025 to a low of -$114455.0 in Q3 2025.
- A 4-year average of $29319.4 and a median of $49951.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables plunged 179.5% — and 2025, when it jumped 298.71%.
- Tracing ETST's Change in Receivables over 4 years: stood at $49966.0 in 2023, then sank by 179.5% to -$39721.0 in 2024, then jumped by 298.71% to $78929.0 in 2025, then slumped by 36.73% to $49936.0 in 2026.
- The last three Change in Receivables figures came in at $49936.0 (Q1 2026), $78929.0 (Q4 2025), and -$114455.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Earth Science Tech | 35.67 Mn | 32.85 Mn | 6.28 Mn | 489,891.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 489,891.00 |
| Jun 30, 2026 | 489,891.00 |
| Mar 31, 2026 | 49,936.00 |
| Mar 31, 2026 | 49,936.00 |
| Dec 31, 2025 | 78,929.00 |
| Dec 31, 2025 | 78,929.00 |
| Sep 30, 2025 | -114,455.00 |
| Sep 30, 2025 | -114,455.00 |
| Jun 30, 2025 | 212,580.00 |
| Jun 30, 2025 | 212,580.00 |
| Mar 31, 2025 | -35,157.00 |
| Mar 31, 2025 | -35,157.00 |
| Dec 31, 2024 | -39,721.00 |
| Dec 31, 2024 | -39,721.00 |
| Sep 30, 2024 | -113,745.00 |
| Sep 30, 2024 | -113,745.00 |
| Jun 30, 2024 | 82,264.00 |
| Jun 30, 2024 | 82,264.00 |
| Mar 31, 2024 | 122,597.00 |
| Mar 31, 2024 | 122,597.00 |